Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

DOHMEN NEWS

Learn what's happening in the world of Dohmen and our clients
February 20, 2018

The Dohmen Company to Sell Dohmen Life Science Services Subsidiary to JLL Partners and Water Street Healthcare Partners

Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, have signed a definitive agreement to acquire Dohmen Life Science Services (“DLSS”) from its parent, The Dohmen Company.
learn more
February 13, 2018

DLSS attends Access! 2018 AAM Annual Meeting

The Dohmen Life Science Services (DLSS) team is sharing the value of streamlined outsourced services during day two of Access!
learn more
February 06, 2018

DLSS sponsors 2018 Life Sciences Market Access & Commercialization Summit

Today Dohmen Life Science Services helped kick off the 2018 Life Sciences Market Access & Commercialization Summit in Philadelphia, Pa.
learn more
January 05, 2018

DLSS joins life science innovators and investors at Biotech Showcase

Dohmen Life Science Services to sponsor and exhibit at conference in San Francisco
learn more
December 28, 2017

DLSS awarded ACHC Accreditations

Dohmen Life Science Services earns Specialty Pharmacy and Infusion Pharmacy accreditations from the Accreditation Commission for Health Care (ACHC).
learn more
December 08, 2017

DLSS showcases patient understanding expertise at CBI Patient Journey Mapping Conference

Dohmen Life Science Services to present patient journey insights in Philadelphia.
learn more
Next >